-
1.发明授权公开(公告)号：US08147811B1
公开(公告)日：2012-04-03
申请号：US10019387
申请日：2000-06-29
IPC分类号： A61K8/18
CPC分类号： A61K31/728 , A61K31/715 , A61L15/28 , A61L15/44 , A61L17/005 , A61L17/10 , A61L31/042 , A61L31/16 , A61L2300/00 , A61L2300/236 , A61L2300/404 , A61L2300/414 , A61L2300/45 , A61K31/00 , A61K2300/00 , C08L5/08
摘要： Use of hyaluronic acid derivatives for the preparation of biomaterials for the prevention of the formation and the treatment of cutaneous scars, wherein the hyaluronic acid derivatives are optionally combined with pharmacologically or biologically active compounds.
摘要翻译： 透明质酸衍生物用于制备用于预防皮肤瘢痕形成和治疗的生物材料的透明质酸衍生物，其中任选地与药理学或生物活性化合物组合。
-
2.发明授权公开(公告)号：US07087745B1
公开(公告)日：2006-08-08
申请号：US09958144
申请日：2000-04-06
IPC分类号： C08B37/08 , A61K31/728
CPC分类号： D01F9/00 , C08B37/0072 , C08J9/28 , C08J2201/054 , C08J2203/08 , C08L5/08 , Y02P20/544 , C08L2666/02
摘要： Biocompatible and biodegradable, three-dimensional structures containing hyaluronic acid derivatives, obtained by the technique of precipitation induced by supercritical antisolvent (SAS), can be used in the field of medicine and surgery.
摘要翻译： 通过超临界反溶剂（SAS）诱导的沉淀技术获得的含有透明质酸衍生物的生物相容性和可生物降解的三维结构可用于医学和外科领域。
-
3.发明授权公开(公告)号：US06552184B1
公开(公告)日：2003-04-22
申请号：US09958147
申请日：2001-11-14
IPC分类号： C08B3708
CPC分类号： C08B37/0072 , C08L5/08 , Y02P20/544
摘要： Crosslinked compounds of hyaluronic acid and the derivatives thereof, prepared by the technique of precipitation induced by supercritical antisolvent (SAS), can be used to advantage for the preparation of biomaterials for use in the field of medicine and surgery and in tissue engineering for medical and surgical purposes.
摘要翻译： 通过超临界反溶剂（SAS）诱导的沉淀技术制备的透明质酸及其衍生物的交联化合物可用于制备用于医学和外科领域的生物材料以及用于医学和医学的组织工程中 手术目的。
-
4.发明授权Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide 有权含有棕榈酰乙醇酰胺和硬脂酰乙醇酰胺的药物制剂公开(公告)号：US08487007B2
公开(公告)日：2013-07-16
申请号：US12989786
申请日：2008-04-28
IPC分类号： A61K31/16 , A61P17/00 , A61P17/04 , A61P17/10 , A61P15/02 , A61P15/00 , A61P29/00 , A61P17/08 , C07C233/18 , A61K31/164
CPC分类号： A61K9/0014 , A61K9/0034 , A61K9/06 , A61K9/107
摘要： The invention concerns new pharmaceutical formulations containing a blend of palmitoyl ethanolamide or PEA and stearoyl ethanolamide or SEA compounds as active principles. The formulation is suitable for oral, parenteral, topical, transdermic, rectal, sublingual, nasal, topical, transdermic, rectal, nasal or sublingual administration, whereby the dosage form of said formulations can be in patches, suppositories, ovules, pessaries, aerosol or spray, emulsions, suspensions, solutions. Said pharmaceutical formulations are useful for the treatment or prevention of skin pathologies, for the treatment or prevention of gynaecological pathologies, for the treatment of disorders or pathologies characterized by improper metabolism of fatty acids as well as for the treatment of disorders or pathologies characterized by inflammatory states
摘要翻译： 本发明涉及含有棕榈酰乙醇酰胺或PEA和硬脂酰乙醇酰胺或SEA化合物的共混物作为活性成分的新药物制剂。 该制剂适用于口服，肠胃外，局部，经皮，直肠，舌下，鼻腔，局部，透皮，直肠，鼻或舌下给药，其中所述制剂的剂型可以是贴剂，栓剂，胚珠，阴道栓剂，气雾剂或 喷雾，乳液，悬浮液，溶液。 所述药物制剂可用于治疗或预防皮肤病理学，治疗或预防妇科病症，用于治疗以脂肪酸不适当代谢为特征的病症或病态，以及用于治疗以炎性为特征的疾病或病理学 状态
-
5.发明申请Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide 有权含有棕榈酰乙醇酰胺和硬脂酰乙醇酰胺的药物制剂公开(公告)号：US20110046225A1
公开(公告)日：2011-02-24
申请号：US12989786
申请日：2008-04-28
IPC分类号： A61K31/16 , A61P17/00 , A61P17/06 , A61P17/04 , A61P17/10 , A61P15/02 , A61P15/00 , A61P29/00 , A61P17/08
CPC分类号： A61K9/0014 , A61K9/0034 , A61K9/06 , A61K9/107
摘要： The invention concerns new pharmaceutical formulations containing a blend of palmitoyl ethanolamide or PEA and stearoyl ethanolamide or SEA compounds as active principles. The formulation is suitable for oral, parenteral, topical, transdermic, rectal, sublingual, nasal, topical, transdermic, rectal, nasal or sublingual administration, whereby the dosage form of said formulations can be in patches, suppositories, ovules, pessaries, aerosol or spray, emulsions, suspensions, solutions. Said pharmaceutical formulations are useful for the treatment or prevention of skin pathologies, for the treatment or prevention of gynaecological pathologies, for the treatment of disorders or pathologies characterised by improper metabolism of fatty acids as well as for the treatment of disorders or pathologies characterised by inflammatory states
摘要翻译： 本发明涉及含有棕榈酰乙醇酰胺或PEA和硬脂酰乙醇酰胺或SEA化合物的共混物作为活性成分的新药物制剂。 该制剂适用于口服，肠胃外，局部，经皮，直肠，舌下，鼻腔，局部，透皮，直肠，鼻或舌下给药，其中所述制剂的剂型可以是贴剂，栓剂，胚珠，阴道栓剂，气雾剂或 喷雾，乳液，悬浮液，溶液。 所述药物制剂可用于治疗或预防皮肤病理学，治疗或预防妇科病症，用于治疗以脂肪酸不适当代谢为特征的病症或病态，以及用于治疗以炎性为特征的疾病或病理学 状态
-
-
-
-
搜索结果
5 条记录 (耗时 0.035 秒)
